title: Metabolites: novel therapeutics or "me-too" drugs? Using desvenlafaxine as an example.
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Schwartz
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000627:therapeutic use*; D019389:Cytochrome P-450 CYP2D6 / Q000378:metabolism; D003865:Major Depressive Disorder / Q000188:drug therapy*; D000069468:Desvenlafaxine Succinate; D006801:Humans; D015201:Meta-Analysis as Topic
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000928:Antidepressive Agents; D003511:Cyclohexanols; D019389:Cytochrome P-450 CYP2D6; D000069468:Desvenlafaxine Succinate